Your browser doesn't support javascript.
loading
Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy.
Sparger, Courtney C; Hernandez, Alexandra E; Rojas, Kristin E; Khan, Khadeja; Halfteck, Gili G; Möller, Mecker; Avisar, Eli; Goel, Neha; Crystal, Jessica S; Kesmodel, Susan B.
Afiliação
  • Sparger CC; University of Miami, Miller School of Medicine, Miami, FL, USA.
  • Hernandez AE; DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Rojas KE; Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Khan K; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Halfteck GG; University of Miami, Miller School of Medicine, Miami, FL, USA.
  • Möller M; DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Avisar E; Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Goel N; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Crystal JS; Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Kesmodel SB; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
World J Surg Oncol ; 22(1): 199, 2024 Jul 29.
Article em En | MEDLINE | ID: mdl-39075403
ABSTRACT

BACKGROUND:

Low false negative rates can be achieved with sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) in breast cancer (BC) patients with clinical N1 (cN1) disease. We examined changes in axillary management and oncologic outcomes in BC patients with cN1 disease receiving NAC.

METHODS:

BC patients with biopsy proven cN1 disease treated with NAC were selected from our institutional cancer registry (2014-2017). Patients were grouped by axillary management, axillary lymph node dissection (ALND), SLNB followed by ALND, or SLNB alone. Univariable and multivariable survival analysis for recurrence-free survival (RFS) and overall survival (OS) were performed.

RESULTS:

81 patients met inclusion criteria 31 (38%) underwent ALND, 25 (31%) SLNB + ALND, and 25 (31%) SLNB alone. A SLN was identified in 45/50 (90%) patients who had SLNB. ALND was performed in 25/50 (50%) patients who had SLNB 18 for a + SLNB, 5 failed SLNB, and 2 insufficient SLNs. 25 patients had SLNB alone, 17 were SLN- and 8 SLN+. In the SLNB alone group, 23/25 (92%) patients received adjuvant radiation (RT). 20 (25%) patients developed BC recurrence 14 distant (70%), 3 local (15%), 2 regional + distant (10%), and 1 contralateral (5%). In the SLNB alone group, there was 1 axillary recurrence in a patient with a negative SLNB who did not receive RT. Univariable survival analysis showed significant differences in RFS and OS between axillary management groups, ALND/SLNB + ALND vs. SLNB alone (RFS p = 0.006, OS p = 0.021). On multivariable survival analysis, worse RFS and OS were observed in patients with TNBC (RFS HR 3.77, 95% CI 1.70-11.90, p = 0.023; OS HR 8.10, 95% CI 1.84-35.60, p = 0.006).

CONCLUSIONS:

SLNB alone and RT after NAC in BC patients with cN1 disease who have negative SLNs at surgery provides long-term regional disease control. This analysis provides support for the practice of axillary downstaging with NAC and SLNB alone.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Axila / Neoplasias da Mama / Terapia Neoadjuvante / Biópsia de Linfonodo Sentinela / Excisão de Linfonodo Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: World J Surg Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Axila / Neoplasias da Mama / Terapia Neoadjuvante / Biópsia de Linfonodo Sentinela / Excisão de Linfonodo Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: World J Surg Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos